Publication
Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.
Journal Paper/Review - Sep 28, 2022
Weber Lorenz, Padevit Luis, Müller Timothy, Velz Julia, Vasella Flavio, Voglis Stefanos, Gramatzki Dorothee, Weller Michael, Regli Luca, Sarnthein Johannes, Neidert Marian Christoph
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Print
Pages
Brief description/objective
Maximum safe resection followed by chemoradiotherapy as current standard of care for WHO grade III and IV gliomas can be influenced by the occurrence of perioperative adverse events (AE). The aim of this study was to determine the association of AE with the timing and choice of subsequent treatments as well as with overall survival (OS).